vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Graham Holdings Co (GHC). Click either name above to swap in a different company.
Graham Holdings Co is the larger business by last-quarter revenue ($1.3B vs $829.0M, roughly 1.5× Acadia Healthcare Company, Inc.). Graham Holdings Co runs the higher net margin — 8.7% vs 0.5%, a 8.2% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 0.4%). Over the past eight quarters, Graham Holdings Co's revenue compounded faster (4.2% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
ACHC vs GHC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $1.3B |
| Net Profit | $4.5M | $108.7M |
| Gross Margin | — | — |
| Operating Margin | — | 3.8% |
| Net Margin | 0.5% | 8.7% |
| Revenue YoY | 7.5% | 0.4% |
| Net Profit YoY | -50.8% | -80.2% |
| EPS (diluted) | $0.05 | $24.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.3B | ||
| Q3 25 | $851.6M | $1.3B | ||
| Q2 25 | $869.2M | $1.2B | ||
| Q1 25 | $770.5M | $1.2B | ||
| Q4 24 | $774.2M | $1.2B | ||
| Q3 24 | $815.6M | $1.2B | ||
| Q2 24 | $796.0M | $1.2B |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $108.7M | ||
| Q3 25 | $36.2M | $122.9M | ||
| Q2 25 | $30.1M | $36.7M | ||
| Q1 25 | $8.4M | $23.9M | ||
| Q4 24 | $32.6M | $548.8M | ||
| Q3 24 | $68.1M | $72.5M | ||
| Q2 24 | $78.5M | $-21.0M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 3.8% | ||
| Q3 25 | 4.7% | 5.2% | ||
| Q2 25 | 5.8% | 6.0% | ||
| Q1 25 | 1.7% | 4.1% | ||
| Q4 24 | 4.9% | 5.8% | ||
| Q3 24 | 12.1% | 6.8% | ||
| Q2 24 | 13.4% | 2.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 8.7% | ||
| Q3 25 | 4.3% | 9.6% | ||
| Q2 25 | 3.5% | 3.0% | ||
| Q1 25 | 1.1% | 2.0% | ||
| Q4 24 | 4.2% | 44.1% | ||
| Q3 24 | 8.4% | 6.0% | ||
| Q2 24 | 9.9% | -1.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $24.76 | ||
| Q3 25 | $0.40 | $27.91 | ||
| Q2 25 | $0.33 | $8.35 | ||
| Q1 25 | $0.09 | $5.45 | ||
| Q4 24 | $0.36 | $124.05 | ||
| Q3 24 | $0.74 | $16.42 | ||
| Q2 24 | $0.85 | $-4.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $267.0M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $4.8B |
| Total Assets | $5.5B | $8.4B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $267.0M | ||
| Q3 25 | $118.7M | $190.8M | ||
| Q2 25 | $131.4M | $176.2M | ||
| Q1 25 | $91.2M | $156.7M | ||
| Q4 24 | $76.3M | $260.9M | ||
| Q3 24 | $82.1M | $244.4M | ||
| Q2 24 | $77.2M | $140.7M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $4.8B | ||
| Q3 25 | $3.1B | $4.5B | ||
| Q2 25 | $3.1B | $4.4B | ||
| Q1 25 | $3.0B | $4.3B | ||
| Q4 24 | $3.1B | $4.3B | ||
| Q3 24 | $3.0B | $4.0B | ||
| Q2 24 | $3.0B | $4.0B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $8.4B | ||
| Q3 25 | $6.4B | $7.9B | ||
| Q2 25 | $6.3B | $7.6B | ||
| Q1 25 | $6.1B | $7.6B | ||
| Q4 24 | $6.0B | $7.7B | ||
| Q3 24 | $5.9B | $7.4B | ||
| Q2 24 | $5.7B | $7.2B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $28.3M |
| Free Cash FlowOCF − Capex | — | $5.0M |
| FCF MarginFCF / Revenue | — | 0.4% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | 13.78× | 0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | $275.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $28.3M | ||
| Q3 25 | $73.2M | $178.1M | ||
| Q2 25 | $133.5M | $94.8M | ||
| Q1 25 | $11.5M | $46.0M | ||
| Q4 24 | $116.7M | $116.3M | ||
| Q3 24 | $163.1M | $237.6M | ||
| Q2 24 | $171.1M | $52.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $5.0M | ||
| Q3 25 | $-63.0M | $161.8M | ||
| Q2 25 | $-34.2M | $78.0M | ||
| Q1 25 | $-163.2M | $30.5M | ||
| Q4 24 | $-86.8M | $91.1M | ||
| Q3 24 | $-27.1M | $219.4M | ||
| Q2 24 | $16.9M | $33.7M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 0.4% | ||
| Q3 25 | -7.4% | 12.6% | ||
| Q2 25 | -3.9% | 6.4% | ||
| Q1 25 | -21.2% | 2.6% | ||
| Q4 24 | -11.2% | 7.3% | ||
| Q3 24 | -3.3% | 18.2% | ||
| Q2 24 | 2.1% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 1.9% | ||
| Q3 25 | 16.0% | 1.3% | ||
| Q2 25 | 19.3% | 1.4% | ||
| Q1 25 | 22.7% | 1.3% | ||
| Q4 24 | 26.3% | 2.0% | ||
| Q3 24 | 23.3% | 1.5% | ||
| Q2 24 | 19.4% | 1.5% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | 2.02× | 1.45× | ||
| Q2 25 | 4.43× | 2.58× | ||
| Q1 25 | 1.37× | 1.93× | ||
| Q4 24 | 3.58× | 0.21× | ||
| Q3 24 | 2.39× | 3.28× | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
GHC
| Products | $602.7M | 48% |
| Kaplan International | $251.9M | 20% |
| Manufacturing | $117.8M | 9% |
| Television Broadcasting | $110.5M | 9% |
| Higher Education | $83.8M | 7% |
| Supplemental Education | $74.9M | 6% |
| Related Party | $4.4M | 0% |
